Disease Areas:
Cystic fibrosisDevice Types:
VitaloJAK, Clinical Trial ServicesDOI:
10.1016/j.jcf.2026.03.016This study evaluated the effects of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) on cough frequency, physical activity and sleep quality in adolescents and adults with cystic fibrosis. The VitaloJAK Cough Monitor (Vitalograph) was used as a wearable ambulatory cough monitoring device to objectively measure 24-hour cough frequency throughout the study.
